BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®
ソース:
Nasdaq GlobeNewswire
/
03 11 2023 12:00:00 America/New_York
N/A
シェアする